Guidelines for the treatment of hepatitis C virus infection in injection drug users: status quo in the European Union countries.
about
Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and preventionA national multidisciplinary healthcare network for treatment of hepatitis C in people who inject drugs in SloveniaHCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact.High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).10-year trends in the diagnosis and treatment of hepatitis C and concomitant mental health disorders: 1995 to 2005.Current approaches to HCV infection in current and former injection drug users.Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review.Opioids and HIV/HCV infection.Should active injecting drug users receive treatment for chronic hepatitis C?Treatment and primary prevention in people who inject drugs for chronic hepatitis C infection: is elimination possible in a high-prevalence setting?Substitution treatment and HCV/HIV-infection in a sample of 31 German prisons for sentenced inmates.Directly observed therapy for the treatment of hepatitis C virus infection in current and former injection drug users.Clinical characteristics and outcome for hepatitis C virus-positive diffuse large B-cell lymphoma.Combination therapy of natural human interferon-beta and ribavirin for chronic hepatitis C patients with injection drug use.
P2860
Q27014761-BC7EF4D4-992A-4FBA-BD91-C848ACF0915AQ34260894-9244A6A8-D732-4532-A40C-F08327C425C4Q35535844-35B85A02-2ADC-443A-9F44-E7DDEDC15726Q36123087-3CB83773-AFBA-47A9-AFF3-3CBE80A7345DQ37067965-6D55857B-4DB9-499D-8C20-E2E7B988239CQ37235530-450DC2FC-F1AC-4497-8D19-D5C9AC33AD2DQ37245420-2C0677FD-C6B0-42FD-8A40-61A74FC216DAQ37607856-34BE6B95-977B-4523-9FA1-40D367CC848CQ39961988-C38CFB77-4117-4EB3-B025-2BB81EAD8665Q40364008-1ADA2233-A669-4701-9D5D-5A7B35E31795Q41249969-6C19D197-BB5C-45CD-9AFA-D4E73B335A77Q43039432-9F37F886-8DEB-4ACA-864F-8D68F44257F1Q43047628-6179C7F6-1243-4178-BB0D-E64B1FE4E319Q46671103-90E2D8B2-7697-4057-9F79-20A3C0010FC5
P2860
Guidelines for the treatment of hepatitis C virus infection in injection drug users: status quo in the European Union countries.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Guidelines for the treatment o ...... the European Union countries.
@ast
Guidelines for the treatment o ...... the European Union countries.
@en
type
label
Guidelines for the treatment o ...... the European Union countries.
@ast
Guidelines for the treatment o ...... the European Union countries.
@en
prefLabel
Guidelines for the treatment o ...... the European Union countries.
@ast
Guidelines for the treatment o ...... the European Union countries.
@en
P2093
P50
P356
P1476
Guidelines for the treatment o ...... n the European Union countries
@en
P2093
Bernd Schulte
Christian Haasen
Ingo Schafer
Jens Reimer
Lucas Wiessing
Markus Backmund
Susanne Polywka
P304
P356
10.1086/427456
P407
P478
40 Suppl 5
P577
2005-04-01T00:00:00Z